Frequently Asked Questions
The global transcranial magnetic stimulator market was valued at USD 1.3 Billion in 2022.
The transcranial magnetic stimulator market is expected to grow at a CAGR of 9.30% between 2023 and 2030, reaching USD 2. 4 Billion in 2030.
Repetitive transcranial magnetic stimulator (rTMS) is the leading segment by Type, holding over 38.47% share in terms of value in 2022.
The other segment governs the world’s demand for transcranial magnetic stimulators, holding a massive share of over 41.48% in 2022.
The children segment is expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the transcranial magnetic stimulator industry, with over one-third share in 2022.
The top players include BrainsWay Ltd., Nexstim Plc, Magstim; Neuronetics, Inc.; TMS Neuro Solutions, MagVenture, eNeura, Inc.
The major market drivers are technological developments, rising consumer awareness of products, rising frequency of psychiatric problems, and an increase in the prevalence of neurological disorders.
The TMS stimulator machine’s high price is the major market restraint.
Transcranial magnetic stimulators are becoming more popular in developing nations due to an increase in the number of items in advanced phases of R&D. The focus on treating rare disorders and an increase in the number of regulatory approvals for devices are the major opportunities in the transcranial magnetic stimulator industry.